MULTIVARIATE MODELS FOR PREDICTING PROGRESSION TO AIDS AND SURVIVAL IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PERSONS

被引:40
作者
BLATT, SP
MCCARTHY, WF
BUCKOKRASNICKA, B
MELCHER, GP
BOSWELL, RN
DOLAN, MJ
FREEMAN, TM
RUSNAK, JM
HENSLEY, RE
WARD, WW
BARNES, D
HENDRIX, CW
机构
[1] SW FDN BIOMED RES, CTR AIDS RES, WILFORD HALL MED CTR, DEPT INFECT DIS, SAN ANTONIO, TX 78284 USA
[2] SW FDN BIOMED RES, CTR AIDS RES, WILFORD HALL MED CTR, DEPT ALLERGY IMMUNOL, SAN ANTONIO, TX 78284 USA
[3] SW FDN BIOMED RES, CTR AIDS RES, WILFORD HALL MED CTR, DEPT CLIN IMMUNOL, SAN ANTONIO, TX 78284 USA
[4] MIL MED CONSORTIUM APPL RETROVIRAL RES, SAN ANTONIO, TX USA
[5] HENRY M JACKSON FDN ADV MIL MED, ROCKVILLE, MD USA
[6] UNIFORMED SERV UNIV HLTH SCI, SCH MED, DEPT SURG, BETHESDA, MD 20814 USA
关键词
D O I
10.1093/infdis/171.4.837
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Nine hundred thirty persons enrolled in the US Air Force Human Immunodeficiency Virus (HIV) Natural History Study were evaluated with a standard battery of 30 potential surrogate markers of disease progression. A risk score for predicting progression to AIDS was then calculated for each patient in the cohort by using the four highest-ranking variables from multivariate analysis: percentage of CD4 CD29 cells, anergy status, age, and hemoglobin. For predicting survival, beta(2)-microglobulin replaced age in the Cox model. Stratification according to the risk score demonstrated that rates of progression to AIDS and survival were significantly different between risk groups (P < .0001). The novel combination of these markers results in extremely accurate risk scores, which may serve as the basis for the development of true surrogate markers of disease progression.
引用
收藏
页码:837 / 844
页数:8
相关论文
共 35 条
  • [1] USE OF BETA-2-MICROGLOBULIN LEVEL AND CD4 LYMPHOCYTE COUNT TO PREDICT DEVELOPMENT OF ACQUIRED-IMMUNODEFICIENCY-SYNDROME IN PERSONS WITH HUMAN IMMUNODEFICIENCY VIRUS-INFECTION
    ANDERSON, RE
    LANG, W
    SHIBOSKI, S
    ROYCE, R
    JEWELL, N
    WINKELSTEIN, W
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1990, 150 (01) : 73 - 77
  • [2] [Anonymous], 1992, MMWR Recomm Rep, V41, P1
  • [3] BASS HZ, 1992, J ACQ IMMUN DEF SYND, V5, P215
  • [4] DELAYED-TYPE HYPERSENSITIVITY SKIN TESTING PREDICTS PROGRESSION TO AIDS IN HIV-INFECTED PATIENTS
    BLATT, SP
    HENDRIX, CW
    BUTZIN, CA
    FREEMAN, TM
    WARD, WW
    HENSLEY, RE
    MELCHER, GP
    DONOVAN, DJ
    BOSWELL, RN
    [J]. ANNALS OF INTERNAL MEDICINE, 1993, 119 (03) : 177 - 184
  • [5] CD4+ LYMPHOCYTES ARE AN INCOMPLETE SURROGATE MARKER FOR CLINICAL PROGRESSION IN PERSONS WITH ASYMPTOMATIC HIV-INFECTION TAKING ZIDOVUDINE
    CHOI, SS
    LAGAKOS, SW
    SCHOOLEY, RT
    VOLBERDING, PA
    [J]. ANNALS OF INTERNAL MEDICINE, 1993, 118 (09) : 674 - 680
  • [6] DEGRUTTOLA V, 1993, J ACQ IMMUN DEF SYND, V6, P359
  • [7] DOLAN MJ, 1993, 9 INT C AIDS 4 STD W
  • [8] SUPPRESSION OF INVITRO HEMATOPOIESIS FOLLOWING HUMAN IMMUNODEFICIENCY VIRUS-INFECTION
    DONAHUE, RE
    JOHNSON, MM
    ZON, LI
    CLARK, SC
    GROOPMAN, JE
    [J]. NATURE, 1987, 326 (6109) : 200 - 203
  • [9] SURROGATE END-POINTS IN CLINICAL-TRIALS - GETTING CLOSER TO IDENTIFYING MARKERS FOR SURVIVAL IN AIDS
    ELLENBERG, SS
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1991, 302 (6768): : 63 - 64
  • [10] PREDICTIVE MARKERS FOR THE ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) IN HEMOPHILIACS - PERSISTENCE OF P24 ANTIGEN AND LOW T4 CELL COUNT
    EYSTER, ME
    BALLARD, JO
    GAIL, MH
    DRUMMOND, JE
    GOEDERT, JJ
    [J]. ANNALS OF INTERNAL MEDICINE, 1989, 110 (12) : 963 - 969